Language:
  
[Sign in] [Register]   

EIAab logo

Index > Protein center > FBN1(Gene name) > Human
  • Add your favorite
  • FBN1 (Gene name),
  • Fibrillin-1 (Protein name ),  FBN1_HUMAN from NCBI database.
  • top
  • Come back to page head.
  • |
  • General Annotation
  • |
  • Antigen Annotation
  • |
  • 3D
  • |
  • Predicted Eptitope
  • |
  • Vaild Sequence
  • |
  • Related Databases
  • |
  • Feedback
  • Gene name:
    FBN1(FBN);
    Protein name:
    Fibrillin-1;
    Alternative:

    Organism:
    Human (Homo sapiens). 
    General Annotation
    Sub Unit:
    Interacts with COL16A1. Interacts with integrin alpha-V/beta-3.
    Function:
    Fibrillins are structural components of 10-12 nm extracellular calcium-binding microfibrils, which occur either in association with elastin or in elastin-free bundles. Fibrillin-1-containing microfibrils provide long-term force bearing structural support. Regulates osteoblast maturation by controlling TGF-beta bioavailability and calibrating TGF-beta and BMP levels, respectively.
    Subcellular Location:
    Secreted extracellular space extracellular matrix
    Protein Attributes:
    Sequence length:
    2871
    Sequence:
    50:
    MRRGRLLEIA | LGFTVLLASY | TSHGADANLE | AGNVKETRAS | RAKRRGGGGH | 
    100:
    DALKGPNVCG | SRYNAYCCPG | WKTLPGGNQC | IVPICRHSCG | DGFCSRPNMC | 
    150:
    TCPSGQIAPS | CGSRSIQHCN | IRCMNGGSCS | DDHCLCQKGY | IGTHCGQPVC | 
    200:
    ESGCLNGGRC | VAPNRCACTY | GFTGPQCERD | YRTGPCFTVI | SNQMCQGQLS | 
    250:
    GIVCTKTLCC | ATVGRAWGHP | CEMCPAQPHP | CRRGFIPNIR | TGACQDVDEC | 
    300:
    QAIPGLCQGG | NCINTVGSFE | CKCPAGHKLN | EVSQKCEDID | ECSTIPGICE | 
    350:
    GGECTNTVSS | YFCKCPPGFY | TSPDGTRCID | VRPGYCYTAL | TNGRCSNQLP | 
    400:
    QSITKMQCCC | DAGRCWSPGV | TVAPEMCPIR | ATEDFNKLCS | VPMVIPGRPE | 
    450:
    YPPPPLGPIP | PVLPVPPGFP | PGPQIPVPRP | PVEYLYPSRE | PPRVLPVNVT | 
    500:
    DYCQLVRYLC | QNGRCIPTPG | SCRCECNKGF | QLDLRGECID | VDECEKNPCA | 
    550:
    GGECINNQGS | YTCQCRAGYQ | STLTRTECRD | IDECLQNGRI | CNNGRCINTD | 
    600:
    GSFHCVCNAG | FHVTRDGKNC | EDMDECSIRN | MCLNGMCINE | DGSFKCICKP | 
    650:
    GFQLASDGRY | CKDINECETP | GICMNGRCVN | TDGSYRCECF | PGLAVGLDGR | 
    700:
    VCVDTHMRST | CYGGYKRGQC | IKPLFGAVTK | SECCCASTEY | AFGEPCQPCP | 
    750:
    AQNSAEYQAL | CSSGPGMTSA | GSDINECALD | PDICPNGICE | NLRGTYKCIC | 
    800:
    NSGYEVDSTG | KNCVDINECV | LNSLLCDNGQ | CRNTPGSFVC | TCPKGFIYKP | 
    850:
    DLKTCEDIDE | CESSPCINGV | CKNSPGSFIC | ECSSESTLDP | TKTICIETIK | 
    900:
    GTCWQTVIDG | RCEININGAT | LKSQCCSSLG | AAWGSPCTLC | QVDPICGKGY | 
    950:
    SRIKGTQCED | IDECEVFPGV | CKNGLCVNTR | GSFKCQCPSG | MTLDATGRIC | 
    1000:
    LDIRLETCFL | RYEDEECTLP | IAGRHRMDAC | CCSVGAAWGT | EECEECPMRN | 
    1050:
    TPEYEELCPR | GPGFATKEIT | NGKPFFKDIN | ECKMIPSLCT | HGKCRNTIGS | 
    1100:
    FKCRCDSGFA | LDSEERNCTD | IDECRISPDL | CGRGQCVNTP | GDFECKCDEG | 
    1150:
    YESGFMMMKN | CMDIDECQRD | PLLCRGGVCH | NTEGSYRCEC | PPGHQLSPNI | 
    1200:
    SACIDINECE | LSAHLCPNGR | CVNLIGKYQC | ACNPGYHSTP | DRLFCVDIDE | 
    1250:
    CSIMNGGCET | FCTNSEGSYE | CSCQPGFALM | PDQRSCTDID | ECEDNPNICD | 
    1300:
    GGQCTNIPGE | YRCLCYDGFM | ASEDMKTCVD | VNECDLNPNI | CLSGTCENTK | 
    1350:
    GSFICHCDMG | YSGKKGKTGC | TDINECEIGA | HNCGKHAVCT | NTAGSFKCSC | 
    1400:
    SPGWIGDGIK | CTDLDECSNG | THMCSQHADC | KNTMGSYRCL | CKEGYTGDGF | 
    1450:
    TCTDLDECSE | NLNLCGNGQC | LNAPGGYRCE | CDMGFVPSAD | GKACEDIDEC | 
    1500:
    SLPNICVFGT | CHNLPGLFRC | ECEIGYELDR | SGGNCTDVNE | CLDPTTCISG | 
    1550:
    NCVNTPGSYI | CDCPPDFELN | PTRVGCVDTR | SGNCYLDIRP | RGDNGDTACS | 
    1600:
    NEIGVGVSKA | SCCCSLGKAW | GTPCEMCPAV | NTSEYKILCP | GGEGFRPNPI | 
    1650:
    TVILEDIDEC | QELPGLCQGG | KCINTFGSFQ | CRCPTGYYLN | EDTRVCDDVN | 
    1700:
    ECETPGICGP | GTCYNTVGNY | TCICPPDYMQ | VNGGNNCMDM | RRSLCYRNYY | 
    1750:
    ADNQTCDGEL | LFNMTKKMCC | CSYNIGRAWN | KPCEQCPIPS | TDEFATLCGS | 
    1800:
    QRPGFVIDIY | TGLPVDIDEC | REIPGVCENG | VCINMVGSFR | CECPVGFFYN | 
    1850:
    DKLLVCEDID | ECQNGPVCQR | NAECINTAGS | YRCDCKPGYR | FTSTGQCNDR | 
    1900:
    NECQEIPNIC | SHGQCIDTVG | SFYCLCHTGF | KTNDDQTMCL | DINECERDAC | 
    1950:
    GNGTCRNTIG | SFNCRCNHGF | ILSHNNDCID | VDECASGNGN | LCRNGQCINT | 
    2000:
    VGSFQCQCNE | GYEVAPDGRT | CVDINECLLE | PRKCAPGTCQ | NLDGSYRCIC | 
    2050:
    PPGYSLQNEK | CEDIDECVEE | PEICALGTCS | NTEGSFKCLC | PEGFSLSSSG | 
    2100:
    RRCQDLRMSY | CYAKFEGGKC | SSPKSRNHSK | QECCCALKGE | GWGDPCELCP | 
    2150:
    TEPDEAFRQI | CPYGSGIIVG | PDDSAVDMDE | CKEPDVCKHG | QCINTDGSYR | 
    2200:
    CECPFGYILA | GNECVDTDEC | SVGNPCGNGT | CKNVIGGFEC | TCEEGFEPGP | 
    2250:
    MMTCEDINEC | AQNPLLCAFR | CVNTYGSYEC | KCPVGYVLRE | DRRMCKDEDE | 
    2300:
    CEEGKHDCTE | KQMECKNLIG | TYMCICGPGY | QRRPDGEGCV | DENECQTKPG | 
    2350:
    ICENGRCLNT | RGSYTCECND | GFTASPNQDE | CLDNREGYCF | TEVLQNMCQI | 
    2400:
    GSSNRNPVTK | SECCCDGGRG | WGPHCEICPF | QGTVAFKKLC | PHGRGFMTNG | 
    2450:
    ADIDECKVIH | DVCRNGECVN | DRGSYHCICK | TGYTPDITGT | SCVDLNECNQ | 
    2500:
    APKPCNFICK | NTEGSYQCSC | PKGYILQEDG | RSCKDLDECA | TKQHNCQFLC | 
    2550:
    VNTIGGFTCK | CPPGFTQHHT | SCIDNNECTS | DINLCGSKGI | CQNTPGSFTC | 
    2600:
    ECQRGFSLDQ | TGSSCEDVDE | CEGNHRCQHG | CQNIIGGYRC | SCPQGYLQHY | 
    2650:
    QWNQCVDENE | CLSAHICGGA | SCHNTLGSYK | CMCPAGFQYE | QFSGGCQDIN | 
    2700:
    ECGSAQAPCS | YGCSNTEGGY | LCGCPPGYFR | IGQGHCVSGM | GMGRGNPEPP | 
    2750:
    VSGEMDDNSL | SPEACYECKI | NGYPKRGRKR | RSTNETDASN | IEDQSETEAN | 
    2800:
    VSLASWDVEK | TAIFAFNISH | VSNKVRILEL | LPALTTLTNH | NRYLIESGNE | 
    2850:
    DGFFKINQKE | GISYLHFTKK | KPVAGTYSLQ | ISSTPLYKKK | ELNQLEDKYD | 
    2871:
    KDYLSGELGD | NLKMKIQVLL | H
    3D Structure:
    N/A
    Predicted Eptitope:
    Please Sign in.
    EIAab Sequence  Vaild Sequence:
    Please Sign in.
    Related Databases
    MIM:
    SMR:
    Pfam:
    MIM:
    Pfam:
    String:
    KEGG:
    UniGene:
    Uniprot:
     
    FOR
    ELISA Kit for Human Fibrillin-1
    Cat.:
    E0593m
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    ELISA Kit for Human Fibrillin-1
    Cat.:
    E0593h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    ELISA Kit for Human Fibrillin-1
    Cat.:
    E0593p
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    ELISA Kit for Human Fibrillin-1
    Cat.:
    E0593b
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human Fibrillin-1
    Cat.:
    U0593b
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human Fibrillin-1
    Cat.:
    U0593h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human Fibrillin-1
    Cat.:
    U0593p
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human Fibrillin-1
    Cat.:
    U0593m
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    Polyclonal Antibody for Human Fibrillin-1
    Polyclonal Antibody for Human Fibrillin-1
    Cat.:
    P0593Rb-m
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Polyclonal Antibody for Human Fibrillin-1
    Cat.:
    P0593Rb-h
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Polyclonal Antibody for Human Fibrillin-1
    Monoclonal Antibody for Human Fibrillin-1
    Monoclonal Antibody for Human Fibrillin-1
    Monoclonal Antibody for Human Fibrillin-1
    Monoclonal Antibody for Human Fibrillin-1
    Protein for Human Fibrillin-1
    Protein for Human Fibrillin-1
    Protein for Human Fibrillin-1
    Protein for Human Fibrillin-1

    R&D Technical Data
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    s
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Precision
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.

    Intra-assay Precision (Precision within an assay):Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.

    Intra-Assay CV: ≤3.9%

    Inter-assay Precision (Precision between assays):Three samples of known concentration were tested in five separate assays to assess inter-assay precision.

    Inter-Assay CV: ≤7.7%

    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Recovery
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.

    Recovery was determined by spiking various levels of ACE into serum and plasma .

    Sample Type

    Average(%)

    Recovery Range(%)

    Serum

    99

    91-103

    Plasma

    98

    93-106

     

     

     

     

    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Linearity
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.

     

    The linearity of the kit was assayed by testing samples spiked with appropriate concentration of ACE and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.  

     

    Sample

    1:2

    1:4

    1:8

    1:16

    serum(n=5)

    92-105%

    90-101%

    95-105%

    92-109%

    EDTA plasma(n=5)

    89-95%

    93105%

    89-94%

    90-106%

    heparin plasma(n=5)

    93-104%

     

    94-110%

    101-111%

    91-110%

     

    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    References
    1. 1.
      "Genomic organization of the sequence coding for fibrillin, the defective gene product in Marfan syndrome."
      Pereira L.V. , D'Alessio M. , Ramirez F. , Lynch J.R. , Sykes B. , Pangilinan T. , Bonadio J.
      Hum. Mol. Genet.2:961-968(1993) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA];VARIANT TYR-472
      tissue: Placenta.
    2. 2.
      "Three novel mutations of the fibrillin-1 gene and ten single nucleotide polymorphisms of the fibrillin-3 gene in Marfan syndrome patients."
      Uyeda T. , Takahashi T. , Eto S. , Sato T. , Xu G. , Kanezaki R. , Toki T. , Yonesaka S. , Ito E.
      J. Hum. Genet.49:404-407(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA];VARIANT MFS SER-2663
    3. 3.
      Rieder M.J. , Bertucci C. , Stanaway I.B. , Johnson E.J. , Swanson J.E. , Siegel D.L. , da Ponte S.H. , Igartua C. , Patterson K. , Nickerson D.A.
      Submitted (2009-09) to the EMBL/GenBank/DDBJ databases
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA];VARIANT TYR-472
    4. 5.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA];VARIANT TYR-472
    5. 6.
      "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
      The MGC Project Team
      Genome Res.14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA];VARIANT TYR-472
    6. 7.
      "Fibrillin binds calcium and is coded by cDNAs that reveal a multidomain structure and alternatively spliced exons at the 5' end."
      Corson G.M. , Chalberg S.C. , Dietz H.C. , Charbonneau N.L. , Sakai L.Y.
      Genomics17:476-484(1993) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA];NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-55;VARIANT TYR-472
      tissue: Fibroblast.
      tissue: Placenta.
    7. 8.
      "Partial sequence of a candidate gene for the Marfan syndrome."
      Maslen C.L. , Corson G.M. , Maddox B.K. , Glanville R.W. , Sakai L.Y.
      Nature352:334-337(1991) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 899-2871
    8. 9.
      "Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes."
      Lee B. , Godfrey M. , Vitale E. , Hori H. , Mattei M.-G. , Sarfarazi M. , Tsipouras P. , Ramirez F. , Hollister D.W.
      Nature352:330-334(1991) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 813-1313
    9. 10.
      "The skipping of constitutive exons in vivo induced by nonsense mutations."
      Dietz H.C. , Valle D. , Francomano C.A. , Kendzior R.J. Jr. , Pyeritz R.E. , Cutting G.R.
      Science259:680-683(1993) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 2086-2194
    10. 11.
      "Purification and partial characterization of fibrillin, a cysteine-rich structural component of connective tissue microfibrils."
      Sakai L.Y. , Keene D.R. , Glanville R.W. , Bachinger H.P.
      J. Biol. Chem.266:14763-14770(1991) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: CHARACTERIZATION
    11. 12.
      "Molecular structure and interaction of recombinant human type XVI collagen."
      Kassner A. , Tiedemann K. , Notbohm H. , Ludwig T. , Morgelin M. , Reinhardt D.P. , Chu M.-L. , Bruckner P. , Grassel S.
      J. Mol. Biol.339:835-853(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH COL16A1
    12. 13.
      "Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry."
      Chen R. , Jiang X. , Sun D. , Han G. , Wang F. , Ye M. , Wang L. , Zou H.
      J. Proteome Res.8:651-661(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-448; ASN-1067; ASN-1484 AND ASN-1581
      tissue: Liver.
    13. 14.
      "ADAMTS10 protein interacts with fibrillin-1 and promotes its deposition in extracellular matrix of cultured fibroblasts."
      Kutz W.E. , Wang L.W. , Bader H.L. , Majors A.K. , Iwata K. , Traboulsi E.I. , Sakai L.Y. , Keene D.R. , Apte S.S.
      J. Biol. Chem.286:17156-17167(2011) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH ADAMTS10
    14. 15.
      "ADAMTSL4, a secreted glycoprotein widely distributed in the eye, binds Fibrillin-1 microfibrils and accelerates microfibril biogenesis."
      Gabriel L.A. , Wang L.W. , Bader H. , Ho J.C. , Majors A.K. , Hollyfield J.G. , Traboulsi E.I. , Apte S.S.
      Invest. Ophthalmol. Vis. Sci.53:461-469(2012) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: SUBCELLULAR LOCATION;INTERACTION WITH ADAMTSL4
    15. 16.
      "Solution structure of the transforming growth factor beta-binding protein-like module, a domain associated with matrix fibrils."
      Yuan X. , Downing A.K. , Knott V. , Handford P.A.
      EMBO J.16:6659-6666(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: STRUCTURE BY NMR OF 2054-2125
    16. 17.
      "Calcium binding properties of an epidermal growth factor-like domain pair from human fibrillin-1."
      Knott V. , Downing A.K. , Cardy C.M. , Handford P.A.
      J. Mol. Biol.255:22-27(1996) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: STRUCTURE BY NMR OF 2124-2205
    17. 18.
      "Solution structure of a pair of calcium-binding epidermal growth factor-like domains: implications for the Marfan syndrome and other genetic disorders."
      Downing A.K. , Knott V. , Werner J.M. , Cardy C.M. , Campbell I.D. , Handford P.A.
      Cell85:597-605(1996) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: STRUCTURE BY NMR OF 2124-2205
    18. 19.
      "Software and database for the analysis of mutations in the human FBN1 gene."
      Collod G. , Beroud C. , Soussi T. , Junien C. , Boileau C.
      Nucleic Acids Res.24:137-141(1996) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: REVIEW ON MFS VARIANTS
    19. 20.
      "Marfan Database (second edition): software and database for the analysis of mutations in the human FBN1 gene."
      Collod-Beroud G. , Beroud C. , Ades L. , Black C. , Boxer M. , Brock D.J. , Godfrey M. , Hayward C. , Karttunen L. , Milewicz D. , Peltonen L. , Richards R.I. , Wang W. , Junien C. , Boileau C.
      Nucleic Acids Res.25:147-150(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: REVIEW ON MFS VARIANTS
    20. 21.
      "Fibrillin-1 mutations in Marfan syndrome and other type-1 fibrillinopathies."
      Hayward C. , Brock D.J.H.
      Hum. Mutat.10:415-423(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: REVIEW ON VARIANTS
    21. 22.
      "The molecular genetics of Marfan syndrome and related microfibrillopathies."
      Robinson P.N. , Godfrey M.
      J. Med. Genet.37:9-25(2000) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: REVIEW ON MFS
    22. 23.
      "Mutations of FBN1 and genotype-phenotype correlations in Marfan syndrome and related fibrillinopathies."
      Robinson P.N. , Booms P. , Katzke S. , Ladewig M. , Neumann L. , Palz M. , Pregla R. , Tiecke F. , Rosenberg T.
      Hum. Mutat.20:153-161(2002) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: REVIEW ON VARIANTS
    23. 24.
      "Association of mitral valve prolapse and systemic abnormalities of connective tissue: a phenotypic continuum."
      Glesby M.J. , Pyeritz R.E.
      JAMA262:523-528(1989) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INVOLVEMENT IN OCTD
    24. 25.
      "Structure of the integrin binding fragment from fibrillin-1 gives new insights into microfibril organization."
      Lee S.S. , Knott V. , Jovanovic J. , Harlos K. , Grimes J.M. , Choulier L. , Mardon H.J. , Stuart D.I. , Handford P.A.
      Structure12:717-729(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (1.35 ANGSTROMS) OF 1486-1647 IN COMPLEX WITH CALCIUM IONS;FUNCTION;INTERACTION WITH INTEGRIN ALPHA-V/BETA-3;DISULFIDE BONDS
    25. 26.
      "Structure and interdomain interactions of a hybrid domain: a disulphide-rich module of the fibrillin/LTBP superfamily of matrix proteins."
      Jensen S.A. , Iqbal S. , Lowe E.D. , Redfield C. , Handford P.A.
      Structure17:759-768(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 807-951 IN COMPLEX WITH CALCIUM;DISULFIDE BONDS
    26. 27.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT MFS PRO-1137
    27. 28.
      "Clustering of fibrillin (FBN1) missense mutations in Marfan syndrome patients at cysteine residues in EGF-like domains."
      Dietz H.C. , Saraiva J.M. , Pyeritz R.E. , Cutting G.R. , Francomano C.A.
      Hum. Mutat.1:366-374(1992) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS MFS SER-1249; ARG-1663; SER-2221 AND SER-2307
    28. 29.
      "Marfan phenotype variability in a family segregating a missense mutation in the epidermal growth factor-like motif of the fibrillin gene."
      Dietz H.C. , Pyeritz R.E. , Puffenberger E.G. , Kendzior R.J. Jr. , Corson G.M. , Maslen C.L. , Sakai L.Y. , Francomano C.A. , Cutting G.R.
      J. Clin. Invest.89:1674-1680(1992) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT MFS SER-2307
    29. 30.
      "Four novel FBN1 mutations: significance for mutant transcript level and EGF-like domain calcium binding in the pathogenesis of Marfan syndrome."
      Dietz H.C. , McIntosh I. , Sakai L.Y. , Corson G.M. , Chalberg S.C. , Pyeritz R.E. , Francomano C.A.
      Genomics17:468-475(1993) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS MFS ILE-548 AND ALA-723
    30. 31.
      "A novel fibrillin mutation in the Marfan syndrome which could disrupt calcium binding of the epidermal growth factor-like module."
      Hewett D.R. , Lynch J.R. , Smith R. , Sykes B.C.
      Hum. Mol. Genet.2:475-477(1993) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT MFS SER-2144
    31. 32.
      "Mutation screening of complete fibrillin-1 coding sequence: report of five new mutations, including two in 8-cysteine domains."
      Tynan K. , Comeau K. , Pearson M. , Wilgenbus P. , Levitt D. , Gasner C. , Berg M.A. , Miller D.C. , Francke U.
      Hum. Mol. Genet.2:1813-1821(1993) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS MFS ARG-862; TYR-1117; PRO-1137 AND PHE-1589;VARIANT ALA-1148
    32. 33.
      "A compound-heterozygous Marfan patient: two defective fibrillin alleles result in a lethal phenotype."
      Karttunen L. , Raghunath M. , Loennqvist L. , Peltonen L.
      Am. J. Hum. Genet.55:1083-1091(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS MFS GLY-217 AND ARG-2627
    33. 34.
      "A novel mutation of the fibrillin gene causing ectopia lentis."
      Lonnqvist L. , Child A. , Kainulainen K. , Davidson R. , Puhakka L. , Peltonen L.
      Genomics19:573-576(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT ECTOL1 LYS-2447
    34. 35.
      "Two novel mutations and a neutral polymorphism in EGF-like domains of the fibrillin gene (FBN1): SSCP screening of exons 15-21 in Marfan syndrome patients."
      Hayward C. , Rae A.L. , Porteous M.E.M. , Logie L.J. , Brock L.J.
      Hum. Mol. Genet.3:373-375(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT MFS CYS-627
    35. 36.
      "An extra cysteine in one of the non-calcium-binding epidermal growth factor-like motifs of the FBN1 polypeptide is connected to a novel variant of Marfan syndrome."
      Stahl-Hallengren C. , Ukkonen T. , Kainulainen K. , Kristofersson U. , Saxne T. , Tornqvist K. , Peltonen L.
      J. Clin. Invest.94:709-713(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT MFS CYS-122
    36. 37.
      "A new missense mutation of fibrillin in a patient with Marfan syndrome."
      Hewett D.R. , Lynch J.R. , Child A. , Sykes B.C.
      J. Med. Genet.31:338-339(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT MFS TYR-1223
    37. 38.
      "A novel mutation in the fibrillin gene (FBN1) in familial arachnodactyly."
      Hayward C. , Porteous M.E.M. , Brock D.J.H.
      Mol. Cell. Probes8:325-327(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT MFS HIS-1170
    38. 39.
      "Mutations in the fibrillin gene responsible for dominant ectopia lentis and neonatal Marfan syndrome."
      Kainulainen K. , Karttunen L. , Puhakka L. , Sakai L. , Peltonen L.
      Nat. Genet.6:64-69(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS MFS GLY-217; ASN-1023; ARG-1074; TYR-1242; ARG-1513; GLU-2127; TRP-2151; LYS-2447 AND ARG-2511
    39. 40.
      "A Gly1127Ser mutation in an EGF-like domain of the fibrillin-1 gene is a risk factor for ascending aortic aneurysm and dissection."
      Francke U. , Berg M.A. , Tynan K. , Brenn T. , Liu W. , Aoyama T. , Gasner C. , Miller D.C. , Furthmayr H.
      Am. J. Hum. Genet.56:1287-1296(1995) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT SER-1127
    40. 41.
      "Fifteen novel FBN1 mutations causing Marfan syndrome detected by heteroduplex analysis of genomic amplicons."
      Nijbroek G. , Sood S. , McIntosh I. , Francomano C.A. , Bull E. , Pereira L. , Ramirez F. , Pyeritz R.E. , Dietz H.C.
      Am. J. Hum. Genet.57:8-21(1995) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS MFS TYR-129; PHE-166; CYS-746; ARG-926; ARG-1013; LYS-1073; SER-1382 AND ARG-1928
    41. 42.
      "The phenotypic continuum associated with FBN1 mutations includes the Shprintzen-Goldberg syndrome."
      Dietz H.C. , Sood I. , McIntosh I.
      Am. J. Hum. Genet.57:A211-A211(1995)
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT MFS TYR-1223
    42. 43.
      "A mutation in FBN1 disrupts profibrillin processing and results in isolated skeletal features of the Marfan syndrome."
      Milewicz D.M. , Grossfield J. , Cao S.-N. , Kielty C. , Covitz W. , Jewett T.
      J. Clin. Invest.95:2373-2378(1995) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT MFS TRP-2726
    43. 44.
      "Delineation of the Marfan phenotype associated with mutations in exons 23-32 of the FBN1 gene."
      Putnam E.A. , Cho M. , Zinn A.B. , Towbin J.A. , Byers P.H. , Milewicz D.M.
      Am. J. Med. Genet.62:233-242(1996) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS MFS ARG-1053; GLY-1072; LYS-1073 AND GLY-1117
    44. 45.
      "Characterisation of four novel fibrillin-1 (FBN1) mutations in Marfan syndrome."
      Ades L.C. , Haan E.A. , Colley A.F. , Richards R.I.
      J. Med. Genet.33:665-671(1996) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS MFS THR-705; TYR-711; GLY-1055 AND TYR-1153
    45. 46.
      "A novel de novo mutation in exon 14 of the fibrillin-1 gene associated with delayed secretion of fibrillin in a patient with a mild Marfan phenotype."
      Booms P. , Withers A.P. , Boxer M. , Kaufmann U.C. , Hagemeier C. , Vetter U. , Robinson P.N.
      Hum. Genet.100:195-200(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT MFS TYR-587
    46. 47.
      "The pathogenicity of the Pro1148Ala substitution in the FBN1 gene: causing or predisposing to Marfan syndrome and aortic aneurysm, or clinically innocent?"
      Schrijver I. , Liu W. , Francke U.
      Hum. Genet.99:607-611(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT ALA-1148
    47. 48.
      "Mutation screening of all 65 exons of the fibrillin-1 gene in 60 patients with Marfan syndrome: report of 12 novel mutations."
      Hayward C. , Porteous M.E.M. , Brock D.J.H.
      Hum. Mutat.10:280-289(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS MFS ARG-111; CYS-545; CYS-627; GLY-750; ARG-1074; HIS-1170; TRP-1171; LYS-1173; TYR-1404; GLY-1610; LYS-1893; TRP-2099; TYR-2111; ARG-2258; TRP-2282 AND ARG-2489
    48. 49.
      "P1148A in fibrillin-1 is not a mutation leading to Shprintzen-Goldberg syndrome."
      Watanabe Y. , Yano S. , Koga Y. , Yukizane S. , Nishiyori A. , Yoshino M. , Kato H.
      Hum. Mutat.10:326-327(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT ALA-1148
    49. 50.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT ALA-1148
    50. 51.
      "Multiple molecular mechanisms underlying subdiagnostic variants of Marfan syndrome."
      Montgomery R.A. , Geraghty M.T. , Bull E. , Gelb B.D. , Johnson M. , McIntosh I. , Francomano C.A. , Dietz H.C.
      Am. J. Hum. Genet.63:1703-1711(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT MFS ARG-1265
    51. 52.
      "Correlation of a recurrent FBN1 mutation (R122C) with an atypical familial Marfan syndrome phenotype."
      Black C. , Withers A.P. , Gray J.R. , Bridges A.B. , Craig A. , Baty D.U. , Boxer M.
      Hum. Mutat. Suppl.1:S198-S200(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT MFS CYS-122
    52. 53.
      "A novel mutation in the neonatal region of the fibrillin (FBN) 1 gene associated with a classical phenotype of Marfan syndrome (MfS)."
      Grau U. , Klein H.-G. , Detter C. , Mair H. , Welz A. , Seidel D. , Reichart B.
      Hum. Mutat.12:137-137(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT MFS ILE-984
    53. 54.
      "Demonstration of the recurrence of Marfan-like skeletal and cardiovascular manifestations due to germline mosaicism for an FBN1 mutation."
      Collod-Beroud G. , Lackmy-Port-Lys M. , Jondeau G. , Mathieu M. , Maingourd Y. , Coulon M. , Guillotel M. , Junien C. , Boileau C.
      Am. J. Hum. Genet.65:917-921(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT MFS GLU-985
    54. 55.
      "Identification of 9 novel FBN1 mutations in German patients with Marfan syndrome."
      El-Aleem A.A. , Karck M. , Haverich A. , Schmidtke J. , Arslan-Kirchner M.
      Hum. Mutat.14:181-181(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS MFS PHE-504; TYR-1129; CYS-1261; SER-1833 AND TYR-2142
    55. 56.
      "Genotype and phenotype analysis of 171 patients referred for molecular study of the fibrillin-1 gene FBN1 because of suspected Marfan syndrome."
      Loeys B. , Nuytinck L. , Delvaux I. , De Bie S. , De Paepe A.
      Arch. Intern. Med.161:2447-2454(2001) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS MFS PHE-89; CYS-122; CYS-240; CYS-366; CYS-545; SER-560; TYR-570; ASP-592; TRP-598; TYR-776; ARG-781; GLY-913; ARG-985; ARG-1013; TRP-1055; TYR-1055; CYS-1101; PRO-1337; TYR-1339; SER-1429; PRO-1790; TYR-1791; TYR-1835; THR-1909; SER-1915; TYR-1971; TYR-1977; HIS-2223; TRP-2282; TYR-2406; PHE-2581; THR-2585; ARG-2618; LYS-2624 AND CYS-2668;VARIANT ECTOL1 ARG-2154;VARIANT MITRAL VALVE PROLAPSE ILE-1128;VARIANT CYS-1530
    56. 57.
      "TGGE screening of the entire FBN1 coding sequence in 126 individuals with Marfan syndrome and related fibrillinopathies."
      Katzke S. , Booms P. , Tiecke F. , Palz M. , Pletschacher A. , Turkmen S. , Neumann L.M. , Pregla R. , Leitner C. , Schramm C. , Lorenz P. , Hagemeier C. , Fuchs J. , Skovby F. , Rosenberg T. , Robinson P.N.
      Hum. Mutat.20:197-208(2002) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS MFS CYS-62; TYR-587; TYR-596; ASN-654; TYR-681; ARG-683; TRP-685; VAL-723; PHE-734; TYR-748; GLY-776; ARG-781; ARG-908; GLY-921; PRO-1790; SER-1806; VAL-1931 DEL; TYR-1998; GLY-2221; THR-2269 AND TRP-2335;VARIANTS ECTOL1 CYS-115; TYR-661 AND TYR-2339;VARIANT MET-2101
    57. 58.
      "Sensitivity of conformation sensitive gel electrophoresis in detecting mutations in Marfan syndrome and related conditions."
      Koerkkoe J. , Kaitila I. , Loennqvist L. , Peltonen L. , Ala-Kokko L.
      J. Med. Genet.39:34-41(2002) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS MFS CYS-114; ARG-890; GLY-1200; TYR-1835; ARG-2111; CYS-2474 AND GLY-2652;VARIANT ECTOL1 CYS-240
    58. 59.
      "In frame fibrillin-1 gene deletion in autosomal dominant Weill-Marchesani syndrome."
      Faivre L. , Gorlin R.J. , Wirtz M.K. , Godfrey M. , Dagoneau N. , Samples J.R. , Le Merrer M. , Collod-Beroud G. , Boileau C. , Munnich A. , Cormier-Daire V.
      J. Med. Genet.40:34-36(2003) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT WMS2 1692-ARG--TYR-1699 DEL
    59. 60.
      "Detection of thirty novel FBN1 mutations in patients with Marfan syndrome or a related fibrillinopathy."
      Biggin A. , Holman K. , Brett M. , Bennetts B. , Ades L.
      Hum. Mutat.23:99-99(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS MFS SER-154; SER-166; CYS-240; SER-652; THR-705; TYR-711; SER-816; ARG-1013; TYR-1044; GLY-1055; CYS-1101; TYR-1117; TYR-1153; ASN-1155; GLN-1325; LYS-1366; SER-1374; ARG-1389; 1394-GLY--THR-1396 DEL; ALA-1424; TYR-1564; PHE-1770; TRP-1793; GLU-1796; TRP-2442; THR-2585 AND PRO-2623;VARIANT CYS-1530
    60. 61.
      "Consequences of cysteine mutations in calcium-binding epidermal growth factor modules of fibrillin-1."
      Vollbrandt T. , Tiedemann K. , El-Hallous E. , Lin G. , Brinckmann J. , John H. , Baetge B. , Notbohm H. , Reinhardt D.P.
      J. Biol. Chem.279:32924-32931(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: CHARACTERIZATION OF VARIANTS MFS CYS-627; GLY-750 AND ARG-926
    61. 62.
      "Identification of sixty-two novel and twelve known FBN1 mutations in eighty-one unrelated probands with Marfan syndrome and other fibrillinopathies."
      Arbustini E. , Grasso M. , Ansaldi S. , Malattia C. , Pilotto A. , Porcu E. , Disabella E. , Marziliano N. , Pisani A. , Lanzarini L. , Mannarino S. , Larizza D. , Mosconi M. , Antoniazzi E. , Zoia M.C. , Meloni G. , Magrassi L. , Brega A. , more...
      Hum. Mutat.26:494-494(2005) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS MFS CYS-20; TYR-123; ARG-177; ARG-224; GLY-439; 629-VAL--GLY-633 DEL; CYS-635; ILE-636; TYR-832; GLY-890; ASP-1058; SER-1153; PHE-1211 DEL; CYS-1219; ASP-1261; SER-1278; SER-1333; ARG-1402; SER-1424; PHE-1564; GLY-1631; TYR-1663; TYR-1876; ILE-1887; ARG-1895; TYR-1900; PRO-2160; PHE-2221; THR-2385; ARG-2500; TYR-2500; TRP-2535; LYS-2570; ARG-2571; SER-2592; LYS-2610 AND CYS-2629
    62. 63.
      "Identification of 29 novel and nine recurrent fibrillin-1 (FBN1) mutations and genotype-phenotype correlations in 76 patients with Marfan syndrome."
      Rommel K. , Karck M. , Haverich A. , von Kodolitsch Y. , Rybczynski M. , Muller G. , Singh K.K. , Schmidtke J. , Arslan-Kirchner M.
      Hum. Mutat.26:529-539(2005) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS MFS ASN-507 DEL; TYR-541; CYS-627; TYR-781; ARG-985; ARG-1013; VAL-1113; GLY-1284; SER-1475; GLU-1475; THR-1576; ARG-1791; GLY-1928; TYR-1928; TYR-2038; ARG-2085; SER-2144; ARG-2536 AND TYR-2605
    63. 64.
      "Central nervous system abnormalities in two cases with neonatal Marfan syndrome with novel mutations in the fibrillin-1 gene."
      Barnett C.P. , Wilson G.J. , Chiasson D.A. , Gross G.J. , Hinek A. , Hawkins C. , Chitayat D.
      Am. J. Med. Genet. A152:2409-2412(2010) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT MFS GLY-1068
    64. 65.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT ALA-1148
    65. 66.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS SSKS SER-1564; CYS-1570; GLY-1577 AND ASP-1594
    66. 67.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS GPHYSD2 CYS-1696; ASP-1699; CYS-1699; TYR-1706; TRP-1719; THR-1728; VAL-1728; TYR-1733 AND SER-1762;VARIANTS ACMICD CYS-1699; CYS-1700; ARG-1714; CYS-1722; VAL-1726; THR-1728; GLN-1735 INS; ARG-1750 AND VAL-1758
    67. 68.
      "Applying massive parallel sequencing to molecular diagnosis of Marfan and Loeys-Dietz syndromes."
      Baetens M. , Van Laer L. , De Leeneer K. , Hellemans J. , De Schrijver J. , Van De Voorde H. , Renard M. , Dietz H. , Lacro R.V. , Menten B. , Van Criekinge W. , De Backer J. , De Paepe A. , Loeys B. , Coucke P.J.
      Hum. Mutat.32:1053-1062(2011) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS MFS GLY-80; TYR-490; TYR-499; ARG-611; GLY-617; TRP-685; TYR-685; TYR-790; TYR-811; SER-853; TYR-926; SER-1090; ASP-1185; TYR-1284; PHE-1350; ALA-1401; TRP-1431; TYR-1431; ALA-1487; LYS-1489; CYS-1838; TYR-1900; THR-1909; SER-1934; GLY-1976; ARG-1984; ASN-2166; THR-2185; GLY-2247; ARG-2318; TYR-2406; SER-2442; ARG-2511; VAL-2606 DEL; LYS-2610 AND ARG-2646;VARIANTS GLY-1481 AND HIS-2793
    Product Feedback Wall
    Hot Genes
    Atf2 ASPRO ACE ALCAM C19orf80 Trap1a Gdf5
    Top Searches
    Ubiquitin-protein ligase metalloproteinase Ubiquitin ELISA Alpha Tumor necrosis Asprosin TRAP1A
    Why choose EIAAB
    Our products have been quoted by many publications in famous journals such as Cell; Cell Metabolism; Hepatology; Biomaterials.more
    Further Information
    About us Protein center Bank account Distributors Terms & Conditions Career eiaab.com.cn

    Copyright & copy www.eiaab.com2006-2016 All Rights Reserved    EIAab         Email:eiaab@eiaab.com

    鄂ICP备10015095号-1

    鄂公网安备 42018502005535号

    Twitter